Journals / Journal of Contemporary Medicine / 2022 / Cilt: 12 - Sayı: 2

Results of adjustable intragastric balloon use according to Body Mass Index values

Vücut Kitle İndeksi değerlerine göre ayarlanabilir intragastrik balon kullanım sonuçları

Pages
339–343
Publication Date
2022-03-15
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Results: It was determined that there was a statistically significant decrease between weight, BMI, and EWL values measured at the 4th, 8th, and 12th months after the first application was performed (p 0.05) in morbidly obese patients (BMI≥40), all other differences were statistically significant (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: In our study, it was aimed to compare the results of adjustable intragastric balloons in patients according to body mass index.
📊
Key Findings & Data:Material and Method: We recorded the data of 82 patients that we performed AIGB procedure in the last four years.
💡
Conclusion & Impact:Results: It was determined that there was a statistically significant decrease between weight, BMI, and EWL values measured at the 4th, 8th, and 12th months after the first application was performed (p 0.05) in morbidly obese patients (BMI≥40), all other differences were statistically significant (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Obezite · intragastrik balon · kilo kaybı

Abstract

Aim: In our study, it was aimed to compare the results of adjustable intragastric balloons in patients according to body mass index. Material and Method: We recorded the data of 82 patients that we performed AIGB procedure in the last four years. During the initial implantation of the balloon, inflating was performed with 300-350 cc saline and methylene blue. Body mass index values and excess weight loss ratios of the patients at the time of the balloon removal were noted. Patients' complaints and complications arising after balloon application or additional inflation were reported. Results: It was determined that there was a statistically significant decrease between weight, BMI, and EWL values measured at the 4th, 8th, and 12th months after the first application was performed (p 0.05) in morbidly obese patients (BMI≥40), all other differences were statistically significant (p

Özet

Amaç: Çalışmamızda hastalarda ayarlanabilir intragastrik balonların sonuçlarının vücut kitle indeksine göre karşılaştırılması amaçlandı. Gereç ve Yöntem: Son dört yılda AIGB işlemi yaptığımız 82 hastanın verilerini kaydettik. Balonun ilk implantasyonu sırasında 300-350 cc salin ve metilen mavisi ile şişirme yapıldı. Hastaların ve balonun çıkarıldığı anki vücut kitle indeks değerleri(VKİ) ve kilo verme oranları(EWL) not edildi. Hastaların balon uygulaması veya ek şişirme sonrası oluşan şikayetleri ve komplikasyonları kaydedildi. Bulgular: VKİ ve EWL değerleri arasında ilk uygulama yapıldıktan sonra 4., 8. ve 12. aylarda ölçülen kilolarla istatistiksel olarak anlamlı azalma olduğu belirlendi., (p0.05), diğer tüm farklılıklar istatistiksel olarak anlamlıydı (p

🔖

Cite This Article

TURHAN, V. B., ÖZTÜRK, D., ŞAHİN, M., KESKİN, M., BULUŞ, H. (2022). Results of adjustable intragastric balloon use according to Body Mass Index values. Journal of Contemporary Medicine, Cilt: 12 - Sayı: 2, 339–343. https://ajindex.com/articles/774866

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Buchwald H, Avidor Y, et al. Buchwald, H., Avidor, Y., Braunwald, E., Jensen, M. D., Pories, W., Fahrbach, K. JAMA 2004; 292: 1724-37.
  2. Salcan S., Ezmeci T. Obesity Prevalence and Effective Factors in High School Students in Erzincan City Center. J Contemp Med. 2021; 11(3): 330-334. Mathus-Vliegen EM. Intragastric balloon treatment for obesity: what does it really offer? Dig Dis. 2008;26(1):40–4.
  3. Brooks J, Srivastava ED, Mathus-Vliegen, E. M. H. One-year adjustable intragastric balloons: results in 73 consecutive patients in the U.K. Obes Surg. 2014 May;24(5):813-9. doi: 10.1007/s11695-014-1176-3.
  4. Bustamante, F., Brunaldi, V. O., Bernardo, W. M., de Moura, D. T. H., de Moura, E. T. H., Galvão, M. et al. Obesity Treatment with Botulinum Toxin-A Is Not Effective: a Systematic Review and Meta-Analysis. Obesity Surgery, October 2017, Volume 27, Issue 10, pp 2716–2723.
  5. Machytka, E., Klvana, P., Kornbluth, A., Peikin, S., Mathus-Vliegen, L. E., Gostout, C. et al. Adjustable intragastric balloons: a 12-month pilot trial in endoscopic weight loss management. Obes Surg 2011; 21: 1499-1507. Mathus-Vliegen EM. Endoscopic treatment: the past, the present and the future. Best Pract Res Clin Gastroenterol 2014; 28: 685-702.
  6. Yanovski S.Z., Yanovski JA. Long-term drug treatment for obesity: a systematic and clinical review. JAMA 2014; 311: 74-86.
  7. Chang, S. H., Stoll, C. R., Song, J., Varela, J. E., Eagon, C. J., & Colditz, G. A., et al. The effectiveness and risks of bariatric surgery: an updated systematic review and meta-analysis, 2003-2012. JAMA Surg 2014; 149: 275-287.
  8. Usuy E, Brooks J. Response Rates with the Spatz3 Adjustable Balloon. Obes Surg. 2018 May;28(5):1271-1276.
  9. Calle, E. E., Thun, M. J., Petrelli, J. M., Rodriguez, C., & Heath Jr, C. W. Bodymass index and mortality in a prospective cohort of U.S. adults. N Engl J Med 1999; 341: 1097-1105.
  10. Mitura K, Garnysz K. In search of the ideal patient for the intragastric balloon - short- and long-term results in 70 obese patients. Wideochir Inne Tech Maloinwazyjne 2016; 10: 541-547.
  11. Mion, F., Ibrahim, M., Marjoux, S., Ponchon, T., Dugardeyn, S., Roman, S. et al. Swallowable Obalon® gastric balloons as an aid for weight loss: a pilot feasibility study. Obes Surg 2013; 23: 730-733.
  12. Kim SH, Chun HJ, et al. Current status of intragastric balloon for obesity treatment. World J Gastroenterol. 2016; 5495-504.
  13. Bayraktar O., Özçelik A. A., Öktemgil A. R., Bayraktar B. Intragastric balloon therapy for obesity: Is it safe a